The purpose of the present Phase 1 study was to assess the cardiac safety of Staccato
Loxapine administered to healthy volunteers in a 3 period crossover study.
Phase:
Phase 1
Details
Lead Sponsor:
Alexza Pharmaceuticals, Inc.
Treatments:
Loxapine Moxifloxacin Norgestimate, ethinyl estradiol drug combination